Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics
/PRNewswire/ -- FortySix Venture Capital LLC (46VC) and The University of Tulsa (TU) announced today that technology developed by TU researchers has been...
Source: prnewswire.com